Papers/PMID:39354480
Curcumin extract improves beta cell functions in obese patients with type 2 diabetes: a randomized controlled trial.
Nutrition journal2024The record
6 findings · 1 compound · 6 endpoints · 3 null
What it reported
How to read these marksWhat moved
3 findings
curcumin — decreases body mass index
Evidence strength: moderate.Findingreplicated ×7“The means of body weight and body mass index were significantly lower in the curcumin-treated group compared to the placebo group at visits at 3, 6, 9, and 12 months (Table 2).”
Quoted verbatim from Curcumin extract improves beta cell functions in obese patients with type 2 diabetes: a randomized controlled trial.. - Study
- RCT
- Dose
- curcuminoid extract 250 mg per capsule, three capsules twice daily (1500 mg curcuminoids a day) for 12 months
- Population
- Thai adults with recent type 2 diabetes, BMI 23 or above, all on metformin; difference at 3, 6, 9 and 12 months
Curcumin extract improves beta cell functions in obese patients with type 2 diabetes: a randomized controlled trial.2024PMID:3935448010.1186/s12937-024-01022-3Industry fundedPermalink
curcumin — decreases glycated haemoglobin (HbA1c)
Evidence strength: moderate.Findingreplicated ×4“The means of diabetes-related blood chemistries used to assess diabetic progression, such as HbA1c, FPG, were significantly lower in the curcumin-treated group compared to the placebo group at visits at 3,6, 9, and 12 months (Table 2).”
Quoted verbatim from Curcumin extract improves beta cell functions in obese patients with type 2 diabetes: a randomized controlled trial.. - Study
- RCT
- Dose
- curcuminoid extract 250 mg per capsule, three capsules twice daily (1500 mg curcuminoids a day) for 12 months
- Population
- Thai adults with recent type 2 diabetes, well controlled (HbA1c below 6.5%), BMI 23 or above, all on metformin; difference at 3, 6, 9 and 12 months (Table 2 shows p less than 0.05 at 12 months)
Curcumin extract improves beta cell functions in obese patients with type 2 diabetes: a randomized controlled trial.2024PMID:3935448010.1186/s12937-024-01022-3Industry fundedPermalink
curcumin — increases serum adiponectin
Evidence strength: moderate.Findingreplicated ×3“The level of adiponectin in the placebo-treated group increased, while those of the curcumin-treated group increased significantly and became significantly different from that of the placebo-treated group at the 6-,9- and 12-month visits.”
Quoted verbatim from Curcumin extract improves beta cell functions in obese patients with type 2 diabetes: a randomized controlled trial.. - Study
- RCT
- Dose
- curcuminoid extract 250 mg per capsule, three capsules twice daily (1500 mg curcuminoids a day) for 12 months
- Population
- Thai adults with recent type 2 diabetes, BMI 23 or above, all on metformin; difference at 6, 9 and 12 months
Curcumin extract improves beta cell functions in obese patients with type 2 diabetes: a randomized controlled trial.2024PMID:3935448010.1186/s12937-024-01022-3Industry fundedPermalink
What did not
3 findings
curcumin — no detected effect on serum creatinine concentration
Evidence strength: moderate.FindingNull resultreplicated ×1“We found no significant differences in the mean of AST, ALT and creatinine between the curcumin-treated and placebo-treated group.”
Quoted verbatim from Curcumin extract improves beta cell functions in obese patients with type 2 diabetes: a randomized controlled trial.. - Study
- RCT
- Dose
- curcuminoid extract 250 mg per capsule, three capsules twice daily (1500 mg curcuminoids a day) for 12 months
- Population
- Thai adults with recent type 2 diabetes, all on metformin; safety measure over the 12-month intervention
Curcumin extract improves beta cell functions in obese patients with type 2 diabetes: a randomized controlled trial.2024PMID:3935448010.1186/s12937-024-01022-3Industry fundedPermalink
curcumin — no detected effect on alanine aminotransferase
Evidence strength: limited.FindingNull resultreplicated ×2“We found no significant differences in the mean of AST, ALT and creatinine between the curcumin-treated and placebo-treated group.”
Quoted verbatim from Curcumin extract improves beta cell functions in obese patients with type 2 diabetes: a randomized controlled trial.. - Study
- RCT
- Dose
- curcuminoid extract 250 mg per capsule, three capsules twice daily (1500 mg curcuminoids a day) for 12 months
- Population
- Thai adults with recent type 2 diabetes, all on metformin; safety measure over the 12-month intervention
Curcumin extract improves beta cell functions in obese patients with type 2 diabetes: a randomized controlled trial.2024PMID:3935448010.1186/s12937-024-01022-3Industry fundedPermalink
curcumin — no detected effect on aspartate aminotransferase
Evidence strength: limited.FindingNull resultreplicated ×1“We found no significant differences in the mean of AST, ALT and creatinine between the curcumin-treated and placebo-treated group.”
Quoted verbatim from Curcumin extract improves beta cell functions in obese patients with type 2 diabetes: a randomized controlled trial.. - Study
- RCT
- Dose
- curcuminoid extract 250 mg per capsule, three capsules twice daily (1500 mg curcuminoids a day) for 12 months
- Population
- Thai adults with recent type 2 diabetes, all on metformin; safety measure over the 12-month intervention
Curcumin extract improves beta cell functions in obese patients with type 2 diabetes: a randomized controlled trial.2024PMID:3935448010.1186/s12937-024-01022-3Industry fundedPermalink